Hyperion DeFi, Inc.
As of Oct 22, 2026, Hyperion DeFi is in Stage 2, the uptrend phase, now in its first week (since Oct 19, 2026). It closed at $2.92, 65.0% below its 52-week high and below its 200-day average, which is falling.
Hyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Setup-score rank among Stage 2 peers: #1 of 110 in Biotechnology · #1 of 272 in Health Care
Is HYPD early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
HYPD among Biotechnology401st of 591 by relative strength
All 591 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | GTBP | Stage 2 · wk 7 | 99 | −22.3% |
| 2 | IOVA | Stage 2 · wk 18 | 99 | +38.8% |
| 3 | SLS | Stage 3 · wk 4 | 99 | −1.5% |
| 4 | MRNA | Stage 2 · wk 17 | 99 | +11.3% |
| 5 | TWST | Stage 2 · wk 39 | 99 | −14.5% |
| 6 | KOD | Stage 2 · wk 4 | 99 | +172.1% |
| 7 | ERAS | Stage 3 · wk 5 | 99 | +0.7% |
| 8 | CLYM | Stage 3 · wk 3 | 99 | −15.8% |
| …401 | HYPD | Stage 2 · wk 1 | 18 | −25.5% |
Hyperion DeFi: quick answers
What stage is Hyperion DeFi in?
As of Oct 22, 2026, Hyperion DeFi (HYPD) is in Stage 2, the uptrend phase. It entered Stage 2 on Oct 19, 2026 and is in its first week there. What the four stages mean
Is Hyperion DeFi in an uptrend?
Yes. Hyperion DeFi is in a Stage 2 uptrend. It trades 13.4% below its 200-day average, which is falling.
How far is Hyperion DeFi from its 52-week high?
Hyperion DeFi closed at $2.92 on Oct 22, 2026, 65.0% below its 52-week high of $8.35. Its 52-week low is $2.34.
How has Hyperion DeFi performed over the past year?
As of Oct 22, 2026, Hyperion DeFi is down 61.3% over the past year and down 18.4% so far in 2026.
Which sector and industry is Hyperion DeFi in?
Hyperion DeFi is in the Biotechnology industry, part of the Health Care sector.
About this companyHealth Care· Biotechnology
Hyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem. It is also developing the Optejet User Filled Device to work with various topical ophthalmic liquids, including artificial tears and lens rewetting products. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is based in Dallas, Texas.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.